EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation

Anne T Nies, Jörg König, Patrick Leuthold, Katja Damme, Stefan Winter, Mathias Haag, Satohiro Masuda, Stephan Kruck, Hannelore Daniel, Britta Spanier, Martin F Fromm, Jens Bedke und 3 weitere

Pharmacological Research · 2023

DOI: 10.1016/j.phrs.2023.106941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2023. Verfasst von Anne T Nies und 14 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tuebingen, Germany; Cluster of Excellence iFIT …. Hauptthemen laut MEDLINE: Membrane Transport Proteins, Solute Carrier Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane Transport ProteinsSolute Carrier ProteinsAnimalsMiceLigandsBiological Transport

Stichwörter der Autor:innen

5-Methylcytidine (PubChem CID: 92918)Anserine (PubChem CID: 112072)Capecitabine (PubChem CID: 60953)Cytarabine (PubChem CID: 6253)Cytosine (PubChem CID: 597)Drug screeningDrug transportFlucytosine (PubChem CID: 3366)Gemcitabine (PubChem CID: 60750)In silico screeningMetabolomicsMultidrug and toxin extrusion protein 1Proton-coupled peptide transporter 2

Substanzen

LigandsMembrane Transport ProteinsSolute Carrier Proteins

Autor:innen und Institutionen

  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tuebingen, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies",…
  • Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany, and University of Tuebingen, Germany.
  • Department of Clinical Pharmacology & Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan; Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Himeji Dok…
  • Department of Urology, University Hospital Tuebingen, Germany.
  • TUM School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.

Zitieren

APA

Nies, A. T., König, J., Leuthold, P., Damme, K., Winter, S., Haag, M., Masuda, S., Kruck, S., Daniel, H., Spanier, B., Fromm, M. F., Bedke, J., Inui, K. I., Schwab, M., & Schaeffeler, E. (2023). Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.106941

Vancouver

Nies AT, König J, Leuthold P, Damme K, Winter S, Haag M, et al. Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation. Pharmacological Research. 2023. doi:10.1016/j.phrs.2023.106941

BibTeX
@article{Nies2023,
  author = {Nies, Anne T and König, Jörg and Leuthold, Patrick and Damme, Katja and Winter, Stefan and Haag, Mathias and Masuda, Satohiro and Kruck, Stephan and Daniel, Hannelore and Spanier, Britta and Fromm, Martin F and Bedke, Jens and Inui, Ken-Ichi and Schwab, Matthias and Schaeffeler, Elke},
  title = {Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validation},
  journal = {Pharmacological Research},
  year = {2023},
  doi = {10.1016/j.phrs.2023.106941}
}
Kostenlos starten →